Cargando…
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma
CD204 is a specific marker of tumor‐associated macrophages (TAMs) in glioma. However, the expression levels of CD204 and its involvement in glioma are not fully understood. In this large‐scale study, we assessed the expression and function of CD204 in whole‐grade glioma molecularly and clinically. I...
Autores principales: | Yuan, Yongliang, Zhao, Qitai, Zhao, Songfeng, Zhang, Penghua, Zhao, Haibiao, Li, Zeyun, Du, Yue, Tian, Xin, Lu, Jingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639170/ https://www.ncbi.nlm.nih.gov/pubmed/31140757 http://dx.doi.org/10.1002/cam4.2312 |
Ejemplares similares
-
Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020) -
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma
por: Shigeoka, Manabu, et al.
Publicado: (2015) -
Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020) -
Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019) -
The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)